Europe PMC

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

Abstract 


Protein-energy wasting (PEW) is a major contributor to the high mortality among maintenance hemodialysis (MHD) patients. Cardiovascular disease (CVD) is the leading cause of death in dialysis patients, and PEW can significantly increase cardiovascular mortality in MHD patients. Previous studies have confirmed that PA may be a good objective indicator for determining the nutritional status and prognosis of MHD patients. Our study aimed to determine the predictive value of phase angle (PA) as detected by bioelectrical impedance analysis (BIA) on PEW and cardiovascular (CV) risk among MHD patients. Our retrospective observational study involved 161 adult patients with HD. The Cardiovascular risk score is a risk model based on the Japan Dialysis Outcome and Practice Patterns Study (J-DOPPS). We established LASSO logistic regression analysis model to identify key parameters related to body composition that can predict PEW in MHD patients. The area under the curve (AUC) values for PA, appendicular skeletal muscle mass index (ASMI), body cell mass (BCM), and mid-arm circumference (MAC) in predicting PEW in male MHD patients were relatively large, with 0.708, 0.674, 0.663, and 0.735, respectively. The predicted PEW values of these parameters were slightly lower in female patients than in men. We incorporated PA, ASMI, BCM, and MAC into a model that predicted the incidence of PEW in maintenance hemodialysis patients using LASSO technology. We discovered that the model predicted a greater AUC of PEW occurrence than any single factor, 0.877 for men and 0.76 for women. The results of the univariate logistic regression analysis showed that the low PA tertile array group had a greater incidence of PEW than the high PA group (P < 0.001). Additionally, we also found that lower PA was associated with higher CV risk scores. The PA detected by bioelectrical impedance analysis could predict the risk of PEW and cardiovascular events among patients with MHD. When used in conjunction, PA, ASMI, BCM, and MAC have a high diagnostic efficacy for PEW in patients on maintenance hemodialysis.

Free full text 


Logo of scirepAboutEditorial BoardFor AuthorsScientific Reports
Sci Rep. 2024; 14: 28151.
PMCID: PMC11568186
PMID: 39548164

Phase angle is a useful predicting indicator for protein-energy wasting and cardiovascular risk among maintenance hemodialysis patients

Associated Data

Data Availability Statement

Abstract

Protein-energy wasting (PEW) is a major contributor to the high mortality among maintenance hemodialysis (MHD) patients. Cardiovascular disease (CVD) is the leading cause of death in dialysis patients, and PEW can significantly increase cardiovascular mortality in MHD patients. Previous studies have confirmed that PA may be a good objective indicator for determining the nutritional status and prognosis of MHD patients. Our study aimed to determine the predictive value of phase angle (PA) as detected by bioelectrical impedance analysis (BIA) on PEW and cardiovascular (CV) risk among MHD patients. Our retrospective observational study involved 161 adult patients with HD. The Cardiovascular risk score is a risk model based on the Japan Dialysis Outcome and Practice Patterns Study (J-DOPPS). We established LASSO logistic regression analysis model to identify key parameters related to body composition that can predict PEW in MHD patients. The area under the curve (AUC) values for PA, appendicular skeletal muscle mass index (ASMI), body cell mass (BCM), and mid-arm circumference (MAC) in predicting PEW in male MHD patients were relatively large, with 0.708, 0.674, 0.663, and 0.735, respectively. The predicted PEW values of these parameters were slightly lower in female patients than in men. We incorporated PA, ASMI, BCM, and MAC into a model that predicted the incidence of PEW in maintenance hemodialysis patients using LASSO technology. We discovered that the model predicted a greater AUC of PEW occurrence than any single factor, 0.877 for men and 0.76 for women. The results of the univariate logistic regression analysis showed that the low PA tertile array group had a greater incidence of PEW than the high PA group (P < 0.001). Additionally, we also found that lower PA was associated with higher CV risk scores. The PA detected by bioelectrical impedance analysis could predict the risk of PEW and cardiovascular events among patients with MHD. When used in conjunction, PA, ASMI, BCM, and MAC have a high diagnostic efficacy for PEW in patients on maintenance hemodialysis.

Keywords: Hemodialysis, Protein energy wasting, Bioelectrical impedance analysis, Phase angle, Cardiovascular risk
Subject terms: Medical research, Nephrology, Risk factors

Introduction

Chronic kidney disease (CKD) has attracted global attention in recent years as an epidemiological health problem1. Currently, an estimated 850 million people worldwide are living with CKD. About 1.2 million people die from CKD annually, making it the sixth fastest-growing cause mortality2. Renal replacement treatment is required when chronic kidney disease (CKD) reaches the end stage, which is known as end-stage renal disease (ESRD). Over the past 20 years, hemodialysis (HD) has been the most common kidney replacement therapy and life-sustaining treatment for patients with ESRD3. As CKD progresses, patients may develop combined disorders of muscle catabolism and nutrition, leading to protein-energy wasting (PEW)4,5.

A number of prior studies have identified PEW as a multifactorial, poorly adapted metabolic state primarily characterized by loss of protein mass and energy reserves, which is a major contributor to the high mortality among MHD patients4,68. According to the recent reviews, the prevalence of PEW in dialysis patients may range from 15 to 75%9. The proportion of Chinese patients among the global hemodialysis population has reached 7.4%, and the annual mortality rate has reached approximately 10%, which is related to the high level of PEW10. It has been found that in hemodialysis patients, the PEW condition can be caused by the loss of amino acids and albumin in dialysis, which in turn can trigger an acute inflammatory response10,11. In addition, hemodialysis patients usually require adequate nutritional control, so the patient should limit the intake of micronutrients, all of which may contribute to the occurrence of PEW10,12.

Cardiovascular disease (CVD) is the leading cause of death in dialysis patients, and PEW can significantly increase cardiovascular mortality in the CKD population, particularly in hemodialysis patients13. Therefore, early detection of PEW and cardiovascular risk is particularly important for the survival of hemodialysis patients.

Bioelectrical impedance analysis (BIA) is the measurement of the body’s impedance (Z) to determine body composition, which is the so-called resistance (R) and reactance (Xc) of the human body to alternating current (AC), and it can be expressed as Z2 = R2 + Xc214. By plugging the participant’s height and the obtained impedance values into the regression equations for each study population, the BIA allowed estimates of measures such as fat mass (FM), skeletal muscle mass (SMM), and body water content1416. Phase angle (PA) is a BIA parameter, which is calculated from the relationship between resistance and reactance values11, and the measurement is expressed in degrees (°)17. When alternating current flows through the body, healthy cell membranes act like capacitors to store electrical energy, which can cause a delay in the flow of alternating current. This hysteresis of the current penetrating the interface between cell membranes and tissues creates a phase difference between current and voltage known as PA14. In recent years, studies suggest that PA can indicate the body cell mass and cell membrane function, such as cell membrane integrity14. Previous studies have confirmed the value of PA as an objective indicator for determining the nutritional status and prognosis of HD patients18,19. PA can also be used to assess muscle function and diabetes20.

Our study focused on analyzing the various independent influencing factors that can contribute to both PEW and the risk of cardiovascular disease among patients undergoing maintenance hemodialysis. We aimed to develop a novel predictive model for PEW and enhance the objectivity and simplicity of its diagnosis, thereby improving the quality of life of MHD patients and reducing mortality.

Methods

Study participants

The study population comprised subjects undergoing maintenance hemodialysis at the Blood Purification Center of the First Affiliated Hospital of Nanjing Medical University between June 2019 and March 2021. The study was approved by the Institutional Ethics Committee (file number: KY-2024-058-01). Inclusion criteria was individuals over 18 years old, receiving 4 h of hemodialysis, three times per week, and with a dialysis duration of at least 3 months. Exclusion criteria encompassed patients suffering from active or invasive tumors, pregnancy, a history of severe infection within the past month, and acute severe diseases (such as acute heart failure or acute cerebrovascular disease) within the past 6 months. A total of 161 participants met the inclusion criteria and were included in the study. As this investigation was retrospective and involved the evaluation of data collected during routine clinical practice, the need for prior informed consent was waived by the Ethics Committee of the First Affiliated Hospital of Nanjing Medical University.

Clinical data collection

The general information of patients was collected, including gender, age, height, weight, history of diabetes, history of hypertension, and history of cardiovascular disease. Cardiovascular history is defined as a history of any of the following events: stroke, angina pectoris, angina surgery, heart failure, myocardial infarction or coronary/peripheral artery disease. In addition, various hematological indexes were measured before and after hemodialysis, including WBC (white blood cell count), hs-CRP (high-sensitivity C-reactive protein), SUA (serum uric acid), HB (hemoglobin), TG (triglyceride), TC (total cholesterol), FPG(fasting plasma glucose), ALB(albumin), 25-OH-VD (25-hydroxyvitamin D), HbA1c (hemoglobin), creatinine and urea nitrogen. According to the renal function before and after the dialysis, Kt/V and nPCR (normalized protein catabolic rate) of dialysis adequacy were calculated. Body mass index (BMI) was calculated as weight (in kilograms) divided by the square of height (in meters) after dialysis.

BIA measurement

The body composition, including PA, was assessed by multifrequency bioimpedance analysis (BIA) using InBody S10 (Biospace, Seoul, Korea) software. The evaluation was conducted 30 min after the completion of hemodialysis, with patients positioned in the supine posture. If the obtained data was markedly unusual, patients were requested to undergo repeat measurements the following week. The software analysis includes the evaluation of various parameters such as FM, percent body fat (PBF), fat-free mass (FFM), abdominal visceral fat area (VFA), body cell mass (BCM), extracellular water (ECW), mid-arm circumference (MAC), total body water (TBW), SMM, as well as mid-arm muscle circumference (MAMC). Patients were instructed to eat 2 h prior to dialysis to avoid the disruptive effects of meals and were prohibited from eating during the dialysis session. SMM was considered a measure of appendicular skeletal muscle mass (ASM) and was recorded as ASM. Appendicular skeletal muscle mass index (ASMI) was calculated by dividing ASM by the square of the height (expressed in kg/m2)21. Fat mass index (FMI) was FM divided by the square of height (expressed in kg/m2). The PA was calculated using the reactance and resistance at 50kHz, because the resistance of body’s cells to current was the strongest at this time and the PA value was the largest, and the formula was as follows: PhA (°) = arctangent (Xc/R) * (180/π)14.

Assessment of PEW

Nutritional status was evaluated using protein-energy wasting (PEW) criteria proposed by the International Society for Renal Nutrition and Metabolism (ISRNM), including serum albumin as serum biochemical index, BMI as body mass, creatinine/body surface area (Cr/BSA) as skeletal muscle mass, and nPCR as protein intake22. We set the cut-off values for Alb, Cr/BSA, BMI, and nPCR as 3.8 g/dL, 380μmol/L/m2, 23 kg/m2, and 0.8 g/kg/d, respectively. The diagnosis of PEW was made if at least three of these parameters were less than the specified cut-off values23. BSA was calculated using the DuBois & DuBois formula: 0.007184 × weight0.425 (kg) × height 0. 725(cm)24.

Cardiovascular risk score

In our study, we utilized a novel risk model proposed by the Japan Dialysis Outcome and Practice Patterns Study (J-DOPPS) for the cardiovascular (CV) risk score25. The model represents a new composite prognostic tool specifically designed for predicting cardiovascular events among hemodialysis patients. It incorporates six predictors, namely age, diabetes status, history of cardiovascular events, duration of each dialysis session, and levels of phosphorus and albumin.

Statistical analysis

In this study, we used STATA 14.0 statistical software package and R 4.0.3 software for data management and statistical analysis. Continuous variables were presented as mean ± standard deviation (SD), while categorical variables were expressed as frequency (percentage). In this study, one-way ANOVA was utilized for comparison of the continuous variables between PA groups, and Pearson Chi-square test was used for comparison of categorical variables. To identify factors related to the body composition predicting the occurrence of PEW in maintenance hemodialysis patients, a LASSO logistic regression analysis model was established. The receiver operating characteristic (ROC) curve was plotted, and the accuracy of the model was assessed by calculating the area under the curve (AUC). We employed multivariate logistic regression analysis to probe the relationship between PA and PEW, and covariates such as sex, age, CV score, FPG, SUA, HB and hs-CRP were adjusted. The Kruskal–Wallis test was used to compare the distinction of the CV event risk model scores among subgroups with different PA levels.

Results

The clinical characteristics of hemodialysis patients by PA tertile.

Table Table11 presents the clinical and biochemical baseline characteristics of the 161 subjects, categorized according to the quantiles of phase angle (PA) levels: PA T1 group (< 5), PA T2 group (≥ 5 ~  < 6.2), and PA T3 group (≥ 6.2). Notably, more male patients were identified in the third tertile compared to those in the other tertiles. Additionally, patients in the low PA group exhibited a higher prevalence of diabetes and hypertension, along with elevated cardiovascular risk scores. Different covariates (Age, TC, TG, FPG, BMI, ALB, SUA, VFA, and BCM) exhibited some differences among groups with different PA levels (P < 0.05). There was no significant difference in FMI among different PA levels. However, patients with higher PA also tended to have higher ASMI.

Table 1

Demographics and clinical characteristics of 162 hemodialysis patients under PA tertiles.

VariablesFirst tertile group
(PA < 5) n = 55
Second tertile group
(5  PA < 6.2) n = 59
Third tertile group
(PA  6.2) n = 47
P value among groups
Female/male22/3323/366/410.004
Age, years64.04 ± 12.1757.32 ± 13.3046.49 ± 11.48 < 0.001
BMI, kg/m222.24 ± 3.2522.87 ± 3.7724.01 ± 3.360.037
Diabetes mellitus, n%36(65.5%)23(39.7%)6(12.8%) < 0.001
Hypertension,n%52(94.5%)46(78.0%)39(83.0%)0.041
CV diseases,n%21(38.2%)16(27.1%)9(19.1%)0.101
TC,mmol/l3.32 ± 1.063.77 ± 1.013.70 ± 0.890.042
TG,mmol/l1.34 ± 0.671.61 ± 0.762.00 ± 1.690.011
FPG,mmol/l8.16 ± 4.016.53 ± 3.175.41 ± 1.97 < 0.001
ALB, g/l42.41 ± 4.0543.6 ± 3.6244.86 ± 3.530.005
SUA, μmol/l384.25 ± 97.74402.29 ± 92.69445.98 ± 108.440.007
WBC, 109/l5.81 ± 1.996.27 ± 1.746.33 ± 1.520.251
HB, g/l105.04 ± 19.43103.83 ± 19.90111.11 ± 16.740.121
Kt/V1.38 ± 0.311.34 ± 0.341.20 ± 0.510.059
hs-CRP, mg/l5.00(1.75 ~ 5.84)5.00(3.23 ~ 5.00)5.00(2.61 ~ 5.00)0.281
25-OH-VD, ng/ml14.21 ± 8.7316.03 ± 9.6719.84 ± 17.840.086
VFA, cm2104.60 ± 49.6785.73 ± 40.1371.69 ± 40.37 < 0.001
HbA1c, %8.34 ± 2.487.58 ± 2.045.70 ± 0.800.166
CV Score6.0(4.0 ~ 7.5)3.0(2.0 ~ 5.0)1.0(1.0 ~ 3.0) < 0.001
nPCR0.70 ± 0.260.72 ± 0.220.79 ± 0.240.545
Cr/BSA440.58 ± 100.28535.55 ± 132.39626.67 ± 154.560.567
PBF, %30.80 ± 9.6631.35 ± 8.5829.71 ± 9.260.661
FM, kg19.89 ± 7.7919.01 ± 7.9418.38 ± 7.490.662
FFM, kg41.65 ± 6.5144.22 ± 8.0548.81 ± 8.270.757
ECW, l12.98 ± 2.5112.74 ± 2.9212.63 ± 2.240.436
TBW, l33.73 ± 6.4132.82 ± 8.0532.87 ± 6.160.377
ECW/TBW, %0.40 ± 0.010.38 ± 0.010.37 ± 0.010.551
BCM, kg26.45 ± 4.1128.64 ± 5.1932.24 ± 5.460.019
MAC, cm27.71 ± 2.9028.56 ± 3.5730.34 ± 3.310.328
MAMC, cm21.96 ± 2.0222.91 ± 2.5624.16 ± 2.230.252
FMI, kg/m212.03 ± 4.7811.44 ± 4.6510.95 ± 4.340.472
ASMI, kg/m26.14 ± 0.876.64 ± 1.027.28 ± 1.04 < 0.001

PA phase angle, BMI body mass index, CV cardiovascular risk, TC total cholesterol, TG triglyceride, FPG fasting plasma glucose, ALB albumin, SUA serum uric acid, WBC white blood cell count, HB hemoglobin, hs-CRP high-sensitivity C-reactive protein, 25-OH-VD 25-hydroxyvitamin D, VFA abdominal visceral fat area, HbA1c hemoglobin, CV cardiovascular, nPCR normalized protein catabolic rate, Cr creatinine, BSA body surface area, PBF percent body fat, FM fat mass, FFM fat-free mass, ECW extracellular water, TBW total body water, BCM body cell mass, MAC mid-arm circumference, MAMC mid-arm muscle circumference, FMI fat mass index, ASMI appendicular skeletal muscle mass index.

The predictive value of single index and LASSO model of BIA parameters in PEW evaluation

The AUC of BIA parameters including PA, BCM, ECW, FFMF, ECW/TBW, FM, MAC, MAMC and ASMI for predicting PEW in male maintenance hemodialysis patients were found to be 0.708, 0.663, 0.551, 0.648, 0.654, 0.665, 0.735, 0.692 and 0.674, respectively (Table (Table2).2). The predicted PEW values of these parameters were slightly lower in female patients than in men. Through LASSO regression, four BIA feature parameters PA, ASMI, BCM and MAC were identified as statistically significant and subsequently included in the model (Table (Table2).2). The AUC of LASSO model for predicting PEW in male and female patients were 0.877 and 0.76, respectively (Table (Table2).2). The effectiveness of the ROC curve model in predicting the risk of PEW occurrence based on LASSO regression was analyzed, resulting in an AUC of 0.843 (Fig. 1).

Table 2

The AUC of BIA parameters potentially associated with PEW among hemodialysis patients.

VariablesFemaleMale
AUCSEp-value95%CIAUCSEp-value95%CI
PA, °0.5790.0820.3370.418 ~ 0.7400.7080.0520.0010.605 ~ 0.810
BCM, kg0.6230.0790.1360.468 ~ 0.7780.6630.0610.010.544 ~ 0.782
ECW, l0.4830.0810.8370.324 ~ 0.6420.5510.0610.4340.430 ~ 0.670
FFM, kg0.6070.0790.1950.452 ~ 0.7620.6480.0610.020.528 ~ 0.768
ECW/TBW, %0.4460.0840.5140.282 ~ 0.6110.6540.0540.0150.548 ~ 0.760
FM, kg0.5440.0800.5950.387 ~ 0.7000.6650.0600.0090.548 ~ 0.782
MAC, cm0.6140.0770.1680.462 ~ 0.7650.7350.053 < 0.0010.631 ~ 0.839
MAMC, cm0.6810.0750.0280.535 ~ 0.8280.6920.0550.0020.584 ~ 0.800
ASMI, kg/m20.4610.0800.6340.304 ~ 0.6180.6740.0590.0060.559 ~ 0.790
Model*0.7600.0660.0020.632 ~ 0.8890.8770.032 < 0.0010.813 ~ 0.940

The model incorporated PA, ASMI, BCM, and MAC. To refine the variables, we employed the LASSO technique*

PA phase angle, BCM body cell mass, ECW extracellular water, FFM fat-free mass, TBW total body water, FM fat mass, MAC mid-arm circumference, MAMC mid-arm muscle circumference, ASMI appendicular skeletal muscle mass index.

An external file that holds a picture, illustration, etc.
Object name is 41598_2024_78957_Fig1_HTML.jpg

The ROC curve analysis of the LASSO regression model to examine protein-energy wasting in hemodialysis patients. The LASSO regression model incorporated PA, ASMI, BCM, and MAC. ROC receiver operating characteristics, AUC area under the curve, PA phase angle, ASMI appendicular skeletal muscle mass index, BCM body cell mass, MAC mid-arm circumference.

The relationship between phase angle and protein-energy wasting

The multivariate linear regression model was used for assessing relationship between phase angle and PEW (Table (Table3).3). In tertiles of phase angle, a significant decrease in the risk of PEW was observed (P < 0.001). The risk of PEW remained significantly decreased even after adjusting for sex and age (P < 0.001). Moreover, after further adjustment for CV score, FPG, SUA, HB, and hs-CRP, the potential association between lower phase angle and high risk of PEW persisted (P < 0.001). Interestingly, the risk of PEW in the subgroup with the lowest quantile of phase angle was found to be 6.49 times higher than that in the subgroup with the highest quantile.

Table 3

Hazard ratio (95% C.I) of the PA levels for protein-energy wasting (PEW).

Non-PEWPEWModel1Model2Model3
OR95%C.IOR95%C.IOR95%C.I
PA_T345(95.7%)2(4.3%)111111
PA_T256(94.9%)3(5.1%)0.220.136 ~ 6.2540.8950.131 ~ 6.0950.8480.124 ~ 5.783
PA_T136(65.5%)19(34.5%)7.9891.474 ~ 43.3087.2731.302 ~ 40.6246.491.156 ~ 36.434
P for trend < 0.001 < 0.001 < 0.001 < 0.001

Model1: adjusted sex, age.

Model2: adjusted sex, age, CV score.

Model3: adjusted sex, age, CV score, FPG, SUA, HB, hs-CRP.

The LASSO regression model incorporated PA, BCM, and MAC.

C.I confidence interval, PA phase angle, OR odds ratio, CV cardiovascular risk, FPG fasting plasma glucose, SUA serum uric acid, HB hemoglobin, hs-CRP high-sensitivity C-reactive protein, BCM body cell mass, MAC mid-arm circumference.

Cardiovascular (CV) risk score at different phase angle levels

Figure 2 depicts the levels of CV risk score by phase angle classification. The results of one-way analysis of variance revealed significant differences in CV risk scores among different phase angle groups. The three groups were compared in pairwise sequence, and the differences were observed to be statistically significant among all the groups (P < 0.05).

An external file that holds a picture, illustration, etc.
Object name is 41598_2024_78957_Fig2_HTML.jpg

Cardiovascular (CV) risk score levels under different phase angle (PA) classifications in hemodialysis patients.

Discussion

PEW is a prevalent complication in maintenance hemodialysis patients, characterized by various metabolic and nutritional disorders, including protein and fat loss26. PEW is caused by inflammation, catabolic diseases, and reduced nutrient intake27. PEW not only diminishes the quality of life for HD patients but also escalates the risk of hospitalization, morbidity, and mortality28. The concept of PEW was first proposed in 2008 by the International Society of Renal Nutrition and Metabolism (ISRNM) defining it as a pathological state characterized by a combination of malnutrition and hypercatabolic conditions29. Due to the complexity of ISRNM’s proposed comprehensive diagnostic criteria for PEW and the relative lack of nutritionists in China, the routine application of ISRNM guidelines in assessing PEW among maintenance hemodialysis patients in Chinese hospitals is significantly hindered. As a result, our study aimed to identify relatively simple, easy-to-implement methods to evaluate the PEW of hemodialysis patients in China. As a technology for measuring body composition, BIA enables the calculation of various body composition indicators, such as fat, muscle, cell mass, volume load status, etc.28. BIA-derived phase angle has emerged as an important marker to reflect the health and nutritional status of individual cells3032. A growing body of researches indicate that low PA values are associated with malnutrition and an increased risk of nutritional deficiencies, particularly among individuals affected by various diseases32,33. Therefore, this study aimed to explore whether PA could serve as a simple and alternative tool to facilitate the early detection of PEW in MHD patients.

Cells consist of conductive intracellular fluid surrounded by a cell membrane that allows the selective permeation of certain ions. PA is an index that can reflect the relationship between resistance and capacitance, because the electrical properties of extracellular and intracellular fluids are very close to resistance, and the cell membrane can be equivalent to capacitance34,35. The baseline data analysis revealed that PA was higher in men compared to women. These sex differences in PA are consistent with previous observations in both healthy subjects36 and diabetic patients37. The relatively higher PA observed in men may be attributed to a larger fat-free mass, resulting in lower resistance38,39. Previous studies of lung cancer patients found that men may have a higher percentage of muscle and a higher percentage of water (both intracellular and extracellular water) than women, and they suggested that PA could be more sensitive to changes in body composition of men34. Moreover, our study corroborates that PA decreases with age, which is consistent with previous findings in healthy subjects40. The biological significance of PA remains unclear, but it is hypothesized to serve as an indicator of cell health, with higher PA values indicating stronger cellular function39,41,42. Interestingly, previous studies have suggested that reductions in PA noted in older individuals reflect declines in overall health and physical function associated with aging41. This may be related to reduced cell integrity and loss of tissue mass, which are commonly observed during the normal aging process41,43,44. In the group with a reduced phase angle, there were significantly more patients with DM, which was consistent with Jun et al. ‘s study 45. They found that the onset of diabetes itself lowered PA values compared with participants without diabetes and that PA values became lower with longer duration of diabetes45. They suggested that PA reduction may reflect tissue damage caused by hyperglycemia or glucose fluctuations. In addition, it is also possible that higher resistance is due to the moderate osmotic effect of hyperglycemia associated with diabetes45,46. The proportion of hypertension was also relatively higher in the lower PA group, which was consistent with previous studies of type 2 diabetes in which people with lower PA were characterized by older age, longer duration of diabetes, and higher systolic blood pressure47. BMI is generally utilized as a measure to assess nutrition status and obesity. Interestingly, our study revealed a positive association between BMI and PA. This finding suggests that higher BMI values are correlated with higher PA values. One plausible explanation for this association is that an increase in BMI may correspond to an increase in the number of fat or muscle cells within the body. This increase in cellular mass could influence reactance and result in higher PA values45.

Our study revealed a significant relationship between phase angle and the risk of developing PEW among maintenance hemodialysis patients. Importantly, this association was found to be independent of traditional risk factors such as sex, age, CV score, FPG, SUA, HB and hs-CRP. However, since previous studies have already established a positive association between PA and indicators of nutrient metabolism, such as albumin and BMI45,48, similar to our results, we hypothesized that the detrimental effects associated with low levels of PA may manifest at the early stages of PEW development.

Body cell mass (BCM), which can be measured using BIA, represents a component of lean tissue devoid of bone mass and extracellular water, making it a valuable indicator of metabolically active tissues49,50. The loss of BCM can be masked by an increase in extracellular water volume, thus keeping lean tissue stable49. Therefore, BCM can act as a sensitive indicator of lean tissue loss. In addition, study conducted by Ruperto et al. confirmed that PEW patients exhibit lower body cell mass compared to well-nourished patients51. Our study also validated that BCM was independently associated with the risk of protein-energy wasting among male patients. Additionally, the mid-arm muscle circumference (MAMC) has been suggested as a marker reflecting muscle mass adequacy, caloric intake, and protein status, serving as an early indicator of malnutrition and nutrient depletion52. A study performed among 133 hemodialysis patients in Bangladesh reported a prevalence of PEW of 18%, with these patients exhibiting significantly lower MAMC values compared to those without PEW [(19.4 ± 2.4)cm vs. (22.2 ± 3.8)cm]26. Interestingly, our study found that MAMC had some predictive values for the occurrence of PEW in both males and females. Although PEW is a wasting of muscle and fat loss, the baseline data showed no statistical difference between different levels of PA and FMI, so the LASSO model did not include FMI . Based on these findings, four BIA feature parameters, (including PA, ASMI, BCM and MAC) were selected using LASSO analysis to assess whether their combination could improve the predictive power for PEW. Multivariate logistic regression analysis revealed that PA, ASMI, BCM and MAC were closely associated with PEW among male patients. Furthermore, compared to any single BIA parameter, the LASSO model demonstrated superior predictive ability for the occurrence of PEW, with a much higher area under the curve for males than for females (0.877 vs 0.76).

Patients with end-stage renal disease (ESRD) face a heightened risk of cardiovascular disease, which is the leading cause of mortality in this population53. Hypotension, myocardial stunning and electrolyte imbalance during hemodialysis treatment can cause significant damage to the myocardium53,54. Eventually, these factors lead to subendocardial ischemia, increased left ventricular wall mass, diastolic dysfunction, and the development of severe arrhythmias through complex pathophysiological mechanisms53,55. These cardiovascular complications are specific to hemodialysis patients and significantly elevate the risk of acute coronary syndrome and sudden cardiac death56,57. In this study, we employed the cardiovascular risk score model developed by the Japanese Dialysis Outcomes and Practice Patterns Study (J-DOPPS) to investigate the relationship between PA and the risk of cardiovascular events. Our results revealed that lower PA values were associated with a higher risk of cardiovascular events. Interestingly, prior research conducted among Chinese populations has also demonstrated that low PA can independently predict heart failure in patients undergoing HD and those with diabetes58.

Our study has several limitations that should be acknowledged. Firstly, the sample size was relatively small, which may introduce potential biases and limit the generalizability of our findings. Therefore, future studies should aim to recruit a larger and more diverse sample to enhance the reliability of the results. Secondly, we did not conduct follow-up assessments on the subjects, which prevented us from examining the longitudinal relationship between PA, other BIA parameters, and the prognosis of PEW in maintenance hemodialysis patients.

Thus, moving forward, it would be valuable to conduct longitudinal studies with larger sample sizes to further explore the association between PA, BIA-related parameters, and the prognosis of PEW in maintenance hemodialysis patients. This would provide more comprehensive insights into the role of BIA parameters, including PA, in predicting and managing PEW in this patient population.

Conclusions

Patients with low phase angles were more likely to develop PEW in comparison to patients with higher phase angles. The PA detected by bioelectrical impedance analysis can be potentially used as a valuable predictive tool to predict PEW and its associated risk of cardiovascular events among maintenance hemodialysis patients. This study demonstrated that PA, ASMI, BCM and MAC can serve as significant risk factors for PEW in HD patients. A combination of the above indicators can yield a high diagnostic efficiency for identifying PEW in maintenance hemodialysis patients. Thus. employing a multi-index combined diagnosis approach may offer an objective, simple, and reliable method for evaluating PEW in this patient population.

Acknowledgements

We thank Xuekui Liu for help in statistics.

Author contributions

Y W, Y C and LQ Z drafted this manuscript. L Z, QQ Y, QJ W, ZW T, BR F, SM S and LH C collated and analyzed the data. H Z, Y X and TN X were responsible for the integrity of the work as a whole. All authors have read and approved the final manuscript.

Funding

This work was supported by the National Natural Science Foundation of China (82201713).

Data availability

The datasets used and/or analysed during the current study available from the corresponding author on reasonable request.

Declarations

Competing interests

The authors declare no competing interests.

Ethical declaration

The research was approved by the Ethics Committee of the First Affiliated Hospital of Nanjing Medical University (file number: KY-2024–058-01). As this investigation was retrospective and involved the evaluation of data collected during routine clinical practice, the need for prior informed consent was waived by the Ethics Committee of the First Affiliated Hospital of Nanjing Medical University. The study had been performed in accordance with the Declaration of Helsinki. This research did not include animal studies.

Footnotes

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

These authors contributed equally: Yun Wang, Yu Chen and Liqin Zhang.

Contributor Information

Tongneng Xue, moc.361@481421ntx.

Yong Xu, moc.361@yxyeah.

Hui Zhou, moc.361@309_iuhuohz.

References

1. Belo, L. & Carvalho, M. Chronic kidney disease underlying molecular mechanisms a special issue overview. Int. J. Mol. Sci.24(15), 12363 (2023). [Europe PMC free article] [Abstract] [Google Scholar]
2. Nangaku, M. Global perspective of kidney diseases: Challenges and changes. Nephrology (Carlton).28(Suppl 1), 5–7 (2023). [Abstract] [Google Scholar]
3. Liu, S. et al. Serum Galectin-3 levels and all-cause and cardiovascular mortality in maintenance hemodialysis patients: a prospective cohort study. BMC Nephrol.23(1), 5 (2022). [Europe PMC free article] [Abstract] [Google Scholar]
4. Chen, S. et al. An updated clinical prediction model of protein-energy wasting for hemodialysis patients. Front. Nutr.9, 933745 (2022). [Europe PMC free article] [Abstract] [Google Scholar]
5. Han, Q. et al. A high neutrophil to lymphocyte ratio is associated with poor nutritional status in chronic kidney disease patients. Br .J. Nutr.128(10), 1990–1996 (2022). [Abstract] [Google Scholar]
6. Hanna, R. M., Ghobry, L., Wassef, O., Rhee, C. M. & Kalantar-Zadeh, K. A practical approach to nutrition, protein-energy wasting, sarcopenia, and cachexia in patients with chronic kidney disease. Blood Purif.49(1–2), 202–211 (2020). [Abstract] [Google Scholar]
7. Rotondi, S. et al. Association between cognitive impairment and malnutrition in hemodialysis patients: two sides of the same coin. Nutrients15(4), 813 (2023). [Europe PMC free article] [Abstract] [Google Scholar]
8. Miyasato, Y., Hanna, R. M., Morinaga, J., Mukoyama, M. & Kalantar-Zadeh, K. Prognostic nutritional index as a predictor of mortality in 101,616 patients undergoing hemodialysis. Nutrients15(2), 311 (2023). [Europe PMC free article] [Abstract] [Google Scholar]
9. Carrero, J. J. et al. Global prevalence of protein-energy wasting in kidney disease: a meta-analysis of contemporary observational studies from the international society of renal nutrition and metabolism. J. Ren. Nutr.28(6), 380–392 (2018). [Abstract] [Google Scholar]
10. Song, Y. et al. A comparison of dietary intake between individuals undergoing maintenance Hemodialysis in the United Kingdom and China. J. Ren. Nutr.32(2), 224–233 (2022). [Europe PMC free article] [Abstract] [Google Scholar]
11. Pawlaczyk, W. et al. Assessment of the nutritional status and quality of life in chronic kidney disease and kidney transplant patients: a comparative analysis. Nutrients14(22), 4814 (2022). [Europe PMC free article] [Abstract] [Google Scholar]
12. Sualeheen, A. et al. Benchmarking diet quality to assess nutritional risk in hemodialysis patients: applying adequacy and moderation metrics of the hemodialysis-healthy eating index. J. Ren. Nutr.32(6), 726–738 (2022). [Abstract] [Google Scholar]
13. As’habi, A., Najafi, I., Tabibi, H. & Hedayati, M. Prevalence of protein-energy wasting and its association with cardiovascular disease risk factors in iranian peritoneal dialysis patients. Iran J. Kidney Dis.13(1), 48–55 (2019). [Abstract] [Google Scholar]
14. Akamatsu, Y. et al. Phase angle from bioelectrical impedance analysis is a useful indicator of muscle quality. J. Cachexia Sarcopenia Muscle.13(1), 180–189 (2022). [Europe PMC free article] [Abstract] [Google Scholar]
15. Kyle, U. G. et al. Bioelectrical impedance analysis–part I: review of principles and methods. Clin. Nutr.23(5), 1226–1243 (2004). [Abstract] [Google Scholar]
16. Ruperto, M. & Barril, G. The extracellular mass to body cell mass ratio as a predictor of mortality risk in hemodialysis patients. Nutrients14(8), 1659 (2022). [Europe PMC free article] [Abstract] [Google Scholar]
17. De Benedetto, F., Marinari, S. & De Blasio, F. Phase angle in assessment and monitoring treatment of individuals with respiratory disease. Rev. Endocr. Metab. Disord.24(3), 491–502 (2023). [Abstract] [Google Scholar]
18. Bellido, D., García-García, C., Talluri, A., Lukaski, H. C. & García-Almeida, J. M. Future lines of research on phase angle: Strengths and limitations. Rev. Endocr. Metab. Disord.24(3), 563–583 (2023). [Europe PMC free article] [Abstract] [Google Scholar]
19. Guo, Y., Zhang, M., Ye, T., Wang, Z. & Yao, Y. Application of bioelectrical impedance analysis in nutritional management of patients with chronic kidney disease. Nutrients.15(18), 3941 (2023). [Europe PMC free article] [Abstract] [Google Scholar]
20. Zhou, H., Yao, W., Pan, D. & Sun, G. Predicational ability of phase angle on protein energy wasting in kidney disease patients with renal replacement therapy: A cross-sectional study. Food Sci. Nutr.9(7), 3573–3579 (2021). [Europe PMC free article] [Abstract] [Google Scholar]
21. Cheng, K. Y. et al. Diagnosis of sarcopenia by evaluating skeletal muscle mass by adjusted bioimpedance analysis validated with dual-energy X-ray absorptiometry. J. Cachexia Sarcopenia Muscle.12(6), 2163–2173 (2021). [Europe PMC free article] [Abstract] [Google Scholar]
22. Disthabanchong, S. et al. Severe hyperparathyroidism is associated with nutritional impairment in maintenance hemodialysis patients. Front. Nutr.9, 933918 (2022). [Europe PMC free article] [Abstract] [Google Scholar]
23. Yajima, T. & Yajima, K. Association of extracellular water/total body water ratio with protein-energy wasting and mortality in patients on hemodialysis. Sci. Rep.13(1), 14257 (2023). [Europe PMC free article] [Abstract] [Google Scholar]
24. Kittiskulnam, P. et al. Sarcopenia among patients receiving hemodialysis: weighing the evidence. J. Cachexia Sarcopenia Muscle.8(1), 57–68 (2017). [Europe PMC free article] [Abstract] [Google Scholar]
25. Matsubara, Y., Kimachi, M., Fukuma, S., Onishi, Y. & Fukuhara, S. Development of a new risk model for predicting cardiovascular events among hemodialysis patients: Population-based hemodialysis patients from the Japan dialysis outcome and practice patterns study (J-DOPPS). PLoS ONE12(3), e0173468 (2017). [Europe PMC free article] [Abstract] [Google Scholar]
26. Rahman, T. et al. Protein energy wasting in a cohort of maintenance hemodialysis patients in dhaka, Bangladesh. Nutrients14(7), 1469 (2022). [Europe PMC free article] [Abstract] [Google Scholar]
27. Graterol Torres, F. et al. Evolving concepts on inflammatory biomarkers and malnutrition in chronic kidney disease. Nutrients14(20), 4297 (2022). [Europe PMC free article] [Abstract] [Google Scholar]
28. Martín-Del-Campo, F. et al. Gut microbiota disturbances and protein-energy wasting in chronic kidney disease: a narrative review. J. Nephrol.36(3), 873–883 (2023). [Europe PMC free article] [Abstract] [Google Scholar]
29. Koppe, L. & Mak, R. H. Is there a need to “modernize” and “simplify” the diagnostic criteria of protein-energy wasting?. Semin Nephrol.43(2), 151403 (2023). [Abstract] [Google Scholar]
30. Lim, C. K. et al. Bioelectrical impedance analysis derived-phase angle as a pragmatic tool to detect protein energy wasting among multi-ethnic hemodialysis patients. Diagnostics (Basel).11(10), 1745 (2021). [Europe PMC free article] [Abstract] [Google Scholar]
31. Gulin, J. et al. Phase angle as a prognostic indicator of surgical outcomes in patients with gastrointestinal cancer. Radiol Oncol.57(4), 524–529 (2023). [Europe PMC free article] [Abstract] [Google Scholar]
32. Han, B. G. et al. Interaction effect of phase angle and age on femoral neck bone mineral density in patients with non-dialysis chronic kidney disease stage 5. Nutrients15(7), 1680 (2023). [Europe PMC free article] [Abstract] [Google Scholar]
33. Lin, L. Y. et al. Sedentary behavior and phase angle: an objective assessment in physically active and inactive older adults. Nutrients16(1), 101 (2023). [Europe PMC free article] [Abstract] [Google Scholar]
34. Shi, J. et al. Sex differences in the association of phase angle and lung cancer mortality. Front. Nutr.9, 1061996 (2022). [Europe PMC free article] [Abstract] [Google Scholar]
35. Matthews, L., Bates, A., Wootton, S. A. & Levett, D. The use of bioelectrical impedance analysis to predict post-operative complications in adult patients having surgery for cancer: A systematic review. Clin. Nutr.40(5), 2914–2922 (2021). [Abstract] [Google Scholar]
36. Fu, L. et al. Reference data of phase angle using bioelectrical impedance analysis in overweight and obese Chinese. Front. Endocrinol. (Lausanne).13, 924199 (2022). [Europe PMC free article] [Abstract] [Google Scholar]
37. Muramae, N. et al. Determinants of phase angle in Japanese patients with diabetes. Diabetol. Int.14(4), 339–343 (2023). [Europe PMC free article] [Abstract] [Google Scholar]
38. Streb, A. R., Hansen, F., Gabiatti, M. P., Tozetto, W. R. & Del Duca, G. F. Phase angle associated with different indicators of health-related physical fitness in adults with obesity. Physiol. Behav.225, 113104 (2020). [Abstract] [Google Scholar]
39. Kyle, U. G., Soundar, E. P., Genton, L. & Pichard, C. Can phase angle determined by bioelectrical impedance analysis assess nutritional risk? A comparison between healthy and hospitalized subjects. Clin. Nutr.31(6), 875–881 (2012). [Abstract] [Google Scholar]
40. Gonzalez, M. C., Barbosa-Silva, T. G., Bielemann, R. M., Gallagher, D. & Heymsfield, S. B. Phase angle and its determinants in healthy subjects: influence of body composition. Am. J. Clin. Nutr.103(3), 712–716 (2016). [Europe PMC free article] [Abstract] [Google Scholar]
41. Reljic, D. et al. Phase angle and vector analysis from multifrequency segmental bioelectrical impedance analysis: new reference data for older adults. J. Physiol. Pharmacol.10.26402/jpp.2020.4.04 (2020). [Abstract] [Google Scholar]
42. Saad, M. A. et al. Phase angle measured by electrical bioimpedance and global cardiovascular risk in older adults. Geriatr. Gerontol. Int.18(5), 732–737 (2018). [Abstract] [Google Scholar]
43. Kolodziej, M., Ignasiak, Z. & Ignasiak, T. Relationship between bioelectrical impedance parameters and appendicular muscle functional quality in older adults from South-Western Poland. Clin. Interv. Aging.16, 245–255 (2021). [Europe PMC free article] [Abstract] [Google Scholar]
44. Hirose, S. et al. Phase angle as an indicator of sarcopenia, malnutrition, and cachexia in inpatients with cardiovascular diseases. J. Clin. Med.9(8), 2554 (2020). [Europe PMC free article] [Abstract] [Google Scholar]
45. Jun, M. H., Ku, B., Kim, J., Kim, K. H. & Kim, J. U. Mediation effect of the duration of diabetes mellitus on the decrease in bioimpedance phase angles in ethnically Korean people: A multicenter clinical study. J. Diabetes Investig.12(5), 790–802 (2021). [Europe PMC free article] [Abstract] [Google Scholar]
46. Buscemi, S., Blunda, G., Maneri, R. & Verga, S. Bioelectrical characteristics of type 1 and type 2 diabetic subjects with reference to body water compartments. Acta. Diabetol.35(4), 220–223 (1998). [Abstract] [Google Scholar]
47. Low, S. et al. Association between lower phase angle and chronic kidney disease progression in type 2 diabetes patients. Ann. Acad. Med. Singap.52(3), 125–134 (2023). [Abstract] [Google Scholar]
48. Han, B. G., Lee, J. Y., Kim, J. S. & Yang, J. W. Decreased bioimpedance phase angle in patients with diabetic chronic kidney disease stage 5. Nutrients11(12), 2874 (2019). [Europe PMC free article] [Abstract] [Google Scholar]
49. Rymarz, A., Bartoszewicz, Z., Szamotulska, K. & Niemczyk, S. The associations between body cell mass and nutritional and inflammatory markers in patients with chronic kidney disease and in subjects without kidney disease. J. Ren. Nutr.26(2), 87–92 (2016). [Abstract] [Google Scholar]
50. Valente, A., Caetano, C., Oliveira, T. & Garagarza, C. Evaluating haemodialysis patient’s nutritional status: Body mass index or body cell mass index?. Nephrology (Carlton).24(9), 967–974 (2019). [Abstract] [Google Scholar]
51. Ruperto, M., Sánchez-Muniz, F. J. & Barril, G. Predictors of protein-energy wasting in haemodialysis patients: a cross-sectional study. J. Hum. Nutr. Diet.29(1), 38–47 (2016). [Abstract] [Google Scholar]
52. Chao, Y. P., Kao, T. W., Chen, W. L., Peng, T. C. & Wu, L. W. Mid-arm muscle circumference as an indicator of osteoporosis in community-dwelling older men. Arch Gerontol Geriatr.87, 103998 (2020). [Abstract] [Google Scholar]
53. Lai, A. C. et al. A personalized approach to chronic kidney disease and cardiovascular disease: JACC review topic of the week. J. Am. Coll. Cardiol.77(11), 1470–1479 (2021). [Abstract] [Google Scholar]
54. Chiu, D. Y., Sinha, S., Kalra, P. A. & Green, D. Sudden cardiac death in haemodialysis patients: preventative options. Nephrology (Carlton).19(12), 740–749 (2014). [Abstract] [Google Scholar]
55. Cooper, H. A. & Braunwald, E. Clinical importance of stunned and hibernating myocardium. Coron. Artery Dis.12(5), 387–392 (2001). [Abstract] [Google Scholar]
56. Waks, J. W., Tereshchenko, L. G. & Parekh, R. S. Electrocardiographic predictors of mortality and sudden cardiac death in patients with end stage renal disease on hemodialysis. J. Electrocardiol.49(6), 848–854 (2016). [Europe PMC free article] [Abstract] [Google Scholar]
57. Cozzolino, M. et al. Cardiovascular disease in dialysis patients. Nephrol. Dial. Transplant.33(28), 34 (2018). [Europe PMC free article] [Abstract] [Google Scholar]
58. Zeng, Y. et al. Clinical prognostic role of bioimpedance phase angle in diabetic and non-diabetic hemodialysis patients. Asia Pac. J. Clin. Nutr.31(4), 619–625 (2022). [Abstract] [Google Scholar]

Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

Citations & impact 


This article has not been cited yet.

Impact metrics

Alternative metrics

Altmetric item for https://www.altmetric.com/details/170437614
Altmetric
Discover the attention surrounding your research
https://www.altmetric.com/details/170437614

Funding 


Funders who supported this work.

National Natural Science Foundation of China (1)